HER2-POSITIVE GASTRIC CANCER
Clinical trials for HER2-POSITIVE GASTRIC CANCER explained in plain language.
Never miss a new study
Get alerted when new HER2-POSITIVE GASTRIC CANCER trials appear
Sign up with your email to follow new studies for HER2-POSITIVE GASTRIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for stomach cancer: triple therapy enters final testing phase
Disease control Recruiting nowThis study tests whether adding a new experimental drug (HLX22) to the standard two-drug treatment can help people with advanced HER2-positive stomach or gastroesophageal cancer live longer without their cancer growing. About 550 adults who have not had prior treatment for their …
Matched conditions: HER2-POSITIVE GASTRIC CANCER
Phase: PHASE3 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated May 26, 2026 07:00 UTC
-
New hope for stomach cancer: experimental combo targets tough tumors
Disease control Recruiting nowThis study tests a new drug combination for people with advanced HER2-positive stomach or gastroesophageal junction cancer whose tumors also have a protein called PD-L1. About 840 participants will receive either the experimental treatment (rilvegostomig plus chemotherapy and tra…
Matched conditions: HER2-POSITIVE GASTRIC CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 06:47 UTC
-
New drug cocktail shows promise for tough stomach cancer
Disease control Recruiting nowThis study is testing whether adding a drug called fruquintinib to standard chemotherapy and trastuzumab can help control advanced HER2-positive stomach or gastroesophageal junction cancer. It is for people who have not had prior treatment for their metastatic disease. The goal i…
Matched conditions: HER2-POSITIVE GASTRIC CANCER
Phase: PHASE1, PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated May 18, 2026 12:11 UTC